Viewing Study NCT01253668


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-06-26 @ 10:07 PM
Study NCT ID: NCT01253668
Status: TERMINATED
Last Update Posted: 2021-04-13
First Post: 2010-11-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Brivanib Metastatic Renal Cell Carcinoma
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Renal Cell Carcinoma View
Keywords: